导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.59% | 787/1050 |
| 近一周 | -3.61% | 993/1104 |
| 近一月 | -2.43% | 426/1103 |
| 近一季 | 7.16% | 115/1092 |
| 近半年 | -10.09% | 785/1070 |
| 近一年 | -15.10% | 815/1018 |
| 近两年 | 15.17% | 811/926 |
| 近三年 | -2.93% | 702/834 |
| 成立以来 | 65.09% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.69% 700/1070 |
-13.36% 984/1101 |
- - |
- - |
| 2025 | 9.28% 835/1065 |
10.39% 144/1014 |
-6.18% 983/1038 |
14.53% 749/1050 |
-7.87% 829/1065 |
| 2024 | 5.96% 395/1011 |
9.13% 40/960 |
-4.32% 592/983 |
10.13% 613/991 |
-7.84% 817/1011 |
| 2023 | -12.44% 412/952 |
3.51% 409/880 |
-10.71% 788/895 |
2.21% 35/915 |
-7.31% 707/952 |
| 2022 | -10.08% 87/867 |
-16.71% 347/773 |
15.60% 110/806 |
-9.14% 198/845 |
2.78% 284/867 |
| 2021 | -7.41% 455/740 |
-3.66% 288/580 |
8.73% 392/659 |
-13.07% 576/704 |
1.67% 369/740 |
| 2020 | 83.63% 80/554 |
-9.80% 380/419 |
35.00% 74/466 |
18.04% 78/517 |
27.76% 47/554 |
| 2019 | - - |
- - |
- - |
- - |
3.49% 367/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 易方达ESG责任投资股票 VS. 东吴新产业精选股票A(580008) |